Complete Filing Data
Vera Therapeutics, Inc. reported Stockholders Equity of $604.52 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Vera Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$299.6M | -$152.1M | -$96.0M | -$89.1M | -$32.6M | -$53.4M |
| Research And Development Expense | $215.3M | $126.2M | $78.2M | $69.0M | $22.5M | $45.2M |
| Operating Income Loss | -$315.5M | -$167.2M | -$102.0M | -$90.9M | -$34.4M | -$52.2M |
| Operating Expenses | $315.5M | $167.2M | $102.0M | $90.9M | $34.4M | $52.2M |
| Nonoperating Income Expense | $15.9M | $15.0M | $6.0M | $1.8M | $1.8M | -$1.2M |
| General And Administrative Expense | $100.2M | $41.0M | $23.8M | $21.9M | $11.9M | $4.0M |
| Interest Expense | $3.8M | $992.0K | $20.0K | $166.0K | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$299.2M | -$152.0M | -$95.7M | -$89.3M | ||
| Restructuring Reserve Current | $0.00 | $377.0K | $962.0K | |||
| Interest Expense Nonoperating | $7.5M | $7.6M | $3.8M | |||
| Restructuring Reserve Noncurrent | $0.00 | $1.3M | $1.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$80.3M | -$76.5M | -$51.7M | -$46.6M | -$33.7M | -$28.4M | -$20.1M | -$20.2M | -$30.1M | -$24.7M | -$14.9M | -$17.1M | -$7.6M | -$3.4M | -$4.7M | -$4.5M | -$3.6M | -$2.5M |
| Research And Development Expense | $56.5M | $58.2M | $41.3M | $40.3M | $29.3M | $23.2M | $16.1M | $16.2M | $25.1M | $19.7M | $10.1M | $12.5M | $3.6M | $3.2M | $2.9M | $2.0M | $2.0M | $1.4M |
| Operating Income Loss | -$83.9M | -$80.1M | -$57.2M | -$49.8M | -$37.3M | -$31.1M | -$21.8M | -$22.0M | -$31.3M | -$25.2M | -$15.1M | -$17.0M | -$7.3M | -$5.8M | -$4.7M | -$4.0M | -$3.2M | -$2.5M |
| Operating Expenses | $83.9M | $80.1M | $57.2M | $49.8M | $37.3M | $31.1M | $21.8M | $22.0M | $31.3M | $25.2M | $15.1M | $17.0M | $7.3M | $5.8M | $4.7M | $4.0M | $3.2M | $2.5M |
| Nonoperating Income Expense | $3.6M | $3.6M | $5.5M | $3.2M | $3.6M | $2.7M | $1.7M | $1.8M | $1.2M | $565.0K | $204.0K | -$64.0K | -$359.0K | $2.4M | $2.0K | -$423.0K | -$431.0K | -$3.0K |
| General And Administrative Expense | $27.5M | $21.9M | $15.9M | $9.5M | $8.0M | $7.9M | $5.7M | $5.7M | $6.2M | $5.6M | $4.9M | $4.5M | $3.7M | $2.6M | $1.8M | $652.0K | $1.2M | $1.0M |
| Interest Expense | $1.9M | $1.9M | $943.0K | $914.0K | $874.0K | $147.0K | $128.0K | $118.0K | $0.00 | $0.00 | $0.00 | $64.0K | $63.0K | $24.0K | ||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$79.9M | -$76.7M | -$51.4M | -$45.1M | -$34.0M | -$28.8M | -$20.0M | -$20.3M | -$29.8M | -$24.8M | -$15.0M | |||||||
| Restructuring Reserve Current | $0.00 | $0.00 | $0.00 | $367.0K | $360.0K | $515.0K | ||||||||||||
| Interest Expense Nonoperating | $2.0M | $1.9M | $1.8M | $1.9M | $1.9M | $1.9M | $943.0K | |||||||||||
| Restructuring Reserve Noncurrent | $0.00 | $0.00 | $0.00 | $1.4M | $1.4M | $1.5M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $604.5M | $577.2M | $101.7M | $76.9M | $69.6M | -$89.3M | -$36.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $354.7M | $92.6M | $45.7M | $43.8M | $80.0M | $54.0M | $3.6M |
| Unrealized Gain Loss On Investments | $393.0K | $142.0K | $475.0K | -$224.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $262.1M | $47.0M | $1.9M | -$36.2M | $26.0M | $50.4M | |
| Retained Earnings Accumulated Deficit | -$760.9M | -$461.3M | -$309.1M | -$213.1M | -$124.1M | -$91.4M | |
| Prepaid Expense And Other Assets Current | $14.3M | $10.4M | $11.3M | $11.0M | $2.9M | $557.0K | |
| Liabilities Current | $53.5M | $25.4M | $22.3M | $25.6M | $7.7M | $2.4M | |
| Liabilities And Stockholders Equity | $734.7M | $655.7M | $175.5M | $131.4M | $83.7M | $54.6M | |
| Liabilities | $130.2M | $78.5M | $73.9M | $54.5M | $14.2M | $4.3M | |
| Cash And Cash Equivalents At Carrying Value | $354.7M | $92.6M | $45.7M | $43.5M | $79.7M | $53.7M | |
| Assets Current | $728.9M | $651.2M | $172.0M | $125.7M | $82.5M | $54.3M | |
| Assets | $734.7M | $655.7M | $175.5M | $131.4M | $83.7M | $54.6M | |
| Additional Paid In Capital Common Stock | $1.36B | $1.04B | $410.5M | $290.2M | $193.6M | $2.1M | |
| Accounts Payable Current | $21.9M | $7.7M | $11.1M | $12.0M | $1.4M | $909.0K | |
| Accrued Liabilities Current | $31.0M | $16.2M | $8.7M | $11.0M | $5.9M | $535.0K | |
| Debt Securities Available For Sale Unrealized Gain Loss | $393.0K | $142.0K | $251.0K | -$224.0K | |||
| Equity Securities Fv Ni Gain Loss | -$47.0K | -$809.0K | -$892.0K | ||||
| Accrued Liabilities And Other Liabilities Non Current | $0.00 | $286.0K | $286.0K | $286.0K | $286.0K | ||
| Prepaid Expense And Other Assets Noncurrent | $2.6M | $131.0K | $482.0K | $162.0K | $51.0K | $0.00 | |
| Operating Lease Right Of Use Asset | $1.9M | $3.4M | $2.9M | $5.2M | |||
| Long Term Debt | $74.8M | $50.7M | $49.9M | $24.8M | $4.9M | $0.00 | |
| Property Plant And Equipment Net | $1.4M | $960.0K | $92.0K | $51.0K | $0.00 | ||
| Operating Lease Right Of Use Asset Amortization Expense | $1.4M | $2.1M | $2.2M | $2.3M | $0.00 | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Operating Lease Liability Noncurrent | $1.9M | $2.5M | $1.4M | $3.8M | $0.00 | ||
| Operating Lease Liability Current | $549.0K | $1.5M | $2.4M | $2.6M | $0.00 | ||
| Marketable Securities Current | $359.9M | $548.2M | $115.0M | $71.2M | $0.00 | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $786.0K | $393.0K | $251.0K | -$224.0K | $0.00 | ||
| Restricted Cash Noncurrent | $0.00 | $293.0K | $293.0K | $293.0K | |||
| Issuance Of Common Stock From Underwritten Follow On Offering Net Of Offering Costs | $281.2M | $593.2M | $107.7M | $80.0M | |||
| Marketable Securities Noncurrent | $11.0K | $58.0K | $867.0K | $0.00 | |||
| Operating Lease Payments | $3.0M | $2.7M | $0.00 | ||||
| Equity Securities Fv Ni Unrealized Gain Loss | -$47.0K | -$809.0K | -$892.0K | ||||
| Common Stock Value | $71.0K | $64.0K | $44.0K | $28.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $398.9M | $468.3M | $535.0M | $289.1M | $327.9M | $353.5M | $123.7M | $140.5M | $157.7M | $105.7M | $121.5M | $134.4M | $85.5M | $92.2M | -$93.3M | -$46.9M | -$42.5M | -$38.9M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $57.8M | $49.1M | $55.1M | $27.3M | $25.1M | $69.1M | $27.4M | $33.9M | $137.7M | $30.8M | $50.7M | $111.8M | $86.5M | $92.0M | $49.8M | $1.5M | $4.1M | $6.2M | ||
| Unrealized Gain Loss On Investments | $354.0K | -$127.0K | $261.0K | $1.5M | -$277.0K | -$424.0K | $67.0K | -$138.0K | $220.0K | -$127.0K | -$140.0K | -$12.0K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$37.6M | $23.4M | $93.9M | $31.8M | -$4.1M | $2.6M | ||||||||||||||
| Retained Earnings Accumulated Deficit | -$669.8M | -$589.5M | -$512.9M | -$417.8M | -$371.2M | -$337.5M | -$283.4M | -$263.3M | -$243.2M | -$180.7M | -$156.0M | -$141.1M | -$107.2M | -$99.6M | -$96.2M | |||||
| Prepaid Expense And Other Assets Current | $13.9M | $14.5M | $16.2M | $10.8M | $10.4M | $12.7M | $11.7M | $9.6M | $7.3M | $10.6M | $10.4M | $6.8M | $3.6M | $4.2M | $2.0M | |||||
| Liabilities Current | $41.9M | $33.6M | $21.9M | $26.5M | $18.4M | $14.5M | $24.6M | $26.8M | $23.5M | $15.9M | $17.3M | $20.0M | $4.0M | $3.8M | $3.8M | |||||
| Liabilities And Stockholders Equity | $517.5M | $578.5M | $610.2M | $368.6M | $397.3M | $419.4M | $175.6M | $195.2M | $209.6M | $131.4M | $148.8M | $165.0M | $91.2M | $97.6M | $51.8M | |||||
| Liabilities | $118.6M | $110.3M | $75.2M | $79.5M | $69.4M | $65.8M | $51.9M | $54.7M | $51.9M | $25.7M | $27.3M | $30.5M | $5.7M | $5.5M | $5.6M | |||||
| Cash And Cash Equivalents At Carrying Value | $57.8M | $49.1M | $55.1M | $27.3M | $25.1M | $69.1M | $27.4M | $33.9M | $137.4M | $30.5M | $50.4M | $111.5M | $86.2M | $91.6M | $49.5M | |||||
| Assets Current | $511.3M | $571.4M | $606.1M | $364.1M | $394.7M | $416.4M | $171.6M | $190.6M | $204.4M | $125.0M | $142.3M | $157.7M | $89.8M | $95.9M | $51.5M | |||||
| Assets | $517.5M | $578.5M | $610.2M | $368.6M | $397.3M | $419.4M | $175.6M | $195.2M | $209.6M | $131.4M | $148.8M | $165.0M | $91.2M | $97.6M | $51.8M | |||||
| Additional Paid In Capital Common Stock | $1.07B | $1.06B | $1.05B | $705.8M | $699.5M | $691.1M | $407.2M | $404.0M | $400.9M | $286.6M | $277.6M | $275.6M | $192.7M | $191.7M | $2.8M | |||||
| Accounts Payable Current | $18.0M | $13.2M | $9.3M | $4.6M | $4.7M | $5.2M | $12.3M | $13.3M | $5.3M | $7.0M | $7.1M | $7.3M | $964.0K | $1.7M | $1.4M | |||||
| Accrued Liabilities Current | $23.5M | $19.5M | $11.4M | $20.0M | $11.6M | $7.1M | $9.8M | $11.0M | $15.6M | $6.2M | $7.7M | $10.2M | $2.7M | $1.7M | $1.8M | |||||
| Debt Securities Available For Sale Unrealized Gain Loss | $354.0K | -$127.0K | $261.0K | $1.5M | -$277.0K | -$424.0K | $67.0K | -$138.0K | $220.0K | -$127.0K | -$140.0K | -$12.0K | ||||||||
| Equity Securities Fv Ni Gain Loss | -$7.0K | -$4.0K | -$15.0K | -$28.0K | -$1.0K | -$202.0K | -$256.0K | -$287.0K | -$364.0K | -$281.0K | $0.00 | |||||||||
| Accrued Liabilities And Other Liabilities Non Current | $0.00 | $286.0K | $286.0K | $286.0K | $287.0K | $286.0K | $286.0K | $286.0K | $286.0K | $286.0K | $286.0K | $286.0K | ||||||||
| Prepaid Expense And Other Assets Noncurrent | $3.0M | $3.6M | $114.0K | $140.0K | $460.0K | $473.0K | $470.0K | $465.0K | $166.0K | $149.0K | $82.0K | $67.0K | ||||||||
| Operating Lease Right Of Use Asset | $2.0M | $2.5M | $2.9M | $3.9M | $1.9M | $2.4M | $3.5M | $4.0M | $4.6M | $5.8M | $5.7M | $6.3M | $6.8M | |||||||
| Long Term Debt | $74.6M | $74.5M | $50.9M | $50.5M | $50.3M | $50.1M | $25.0M | $25.0M | $24.9M | $5.0M | $5.0M | $4.9M | ||||||||
| Property Plant And Equipment Net | $1.2M | $1.2M | $1.1M | $368.0K | $155.0K | $81.0K | $34.0K | $40.0K | $45.0K | $56.0K | $21.0K | $16.0K | ||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $457.0K | $517.0K | $579.0K | $564.0K | $0.00 | |||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Operating Lease Liability Noncurrent | $2.1M | $2.2M | $2.4M | $2.6M | $455.0K | $919.0K | $2.0M | $2.6M | $3.2M | $4.5M | $4.8M | $5.4M | ||||||||
| Operating Lease Liability Current | $473.0K | $855.0K | $1.2M | $1.9M | $2.1M | $2.3M | $2.5M | $2.6M | $2.6M | $2.7M | $2.5M | $2.5M | ||||||||
| Marketable Securities Current | $439.6M | $507.7M | $534.7M | $326.1M | $359.3M | $334.6M | $132.5M | $147.1M | $59.8M | $83.9M | $81.5M | $39.4M | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $881.0K | $527.0K | $654.0K | $1.0M | -$450.0K | -$173.0K | -$75.0K | -$142.0K | -$4.0K | -$279.0K | -$152.0K | -$12.0K | ||||||||
| Restricted Cash Noncurrent | $0.00 | $0.00 | $293.0K | $293.0K | $293.0K | $293.0K | $293.0K | $293.0K | $293.0K | |||||||||||
| Issuance Of Common Stock From Underwritten Follow On Offering Net Of Offering Costs | $269.6M | $107.7M | $80.0M | |||||||||||||||||
| Marketable Securities Noncurrent | $13.0K | $29.0K | $57.0K | $122.0K | $324.0K | $580.0K | $1.1M | $1.5M | ||||||||||||
| Operating Lease Payments | $764.0K | $746.0K | $656.0K | |||||||||||||||||
| Equity Securities Fv Ni Unrealized Gain Loss | -$1.0K | $0.00 | ||||||||||||||||||
| Common Stock Value | $64.0K | $64.0K | $64.0K | $55.0K | $55.0K | $54.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $37.9M | $20.8M | $11.5M | $8.9M | $3.0M | $331.0K |
| Share Based Compensation | $37.9M | $20.8M | $11.5M | $8.9M | $3.0M | $331.0K |
| Net Cash Provided By Used In Operating Activities | -$241.1M | -$134.7M | -$92.2M | -$67.6M | -$23.7M | -$34.8M |
| Net Cash Provided By Used In Financing Activities | $308.9M | $606.7M | $133.5M | $101.9M | $53.9M | $85.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.9M | -$981.0K | -$173.0K | $8.2M | $2.3M | $135.0K |
| Increase Decrease In Accrued Liabilities | $14.4M | $7.2M | -$2.2M | $7.0M | $5.4M | $110.0K |
| Increase Decrease In Accounts Payable | $13.9M | -$3.5M | -$873.0K | $10.6M | $475.0K | $567.0K |
| Net Cash Provided By Used In Investing Activities | $194.3M | -$425.0M | -$39.4M | -$70.6M | -$4.2M | -$42.0K |
| Payments To Acquire Property Plant And Equipment | $630.0K | $972.0K | $63.0K | $62.0K | $0.00 | $99.0K |
| Increase Decrease In Other Current Assets | -$51.0K | -$351.0K | $262.0K | $111.0K | $51.0K | -$59.0K |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 7.0M | 13.4M | 1.1M | 2.1M | 550.0K | |
| Payments To Acquire Marketable Securities | $310.4M | $703.0M | $224.9M | $148.5M | $0.00 | |
| Depreciation Amortization And Accretion Net | -$4.1M | -$846.0K | $176.0K | $251.0K | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $506.2M | $275.0M | $176.0M | $78.0M | $0.00 | |
| Proceeds From Issuance Of Common Stock Follow On Offering | $300.0M | $632.5M | $115.0M | $86.1M | $0.00 | |
| Payments Of Stock Issuance Costs On Follow On Offering | $18.4M | $39.3M | $7.3M | $6.1M | $0.00 | |
| Increase Decrease In Operating Lease Liability | -$1.5M | -$2.4M | -$2.6M | -$2.6M | $0.00 | |
| Proceeds From Sale Of Marketable Securities | $0.00 | $4.0M | $9.5M | $0.00 | ||
| Proceeds From Short Swing Settlement | $500.0K | $37.0K | $0.00 | |||
| Payments For Restructuring | $0.00 | $999.0K | $2.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $9.7M | $9.5M | $7.7M | $5.6M | $4.9M | $4.1M | $2.9M | $2.7M | $2.7M | $2.5M | $2.0M | $1.7M | $933.0K | $713.0K | $404.0K | $55.0K | $72.0K | $61.0K |
| Share Based Compensation | $7.7M | $4.1M | $2.7M | $1.7M | $404.0K | $61.0K | ||||||||||||
| Net Cash Provided By Used In Operating Activities | -$54.4M | -$33.8M | -$26.3M | -$9.0M | -$4.1M | -$2.3M | ||||||||||||
| Net Cash Provided By Used In Financing Activities | $1.5M | $276.5M | $108.0M | $80.3M | -$28.0K | $5.0M | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.9M | $392.0K | -$3.7M | $3.9M | $127.0K | $112.0K | ||||||||||||
| Increase Decrease In Accrued Liabilities | -$4.8M | -$1.7M | $4.6M | $4.2M | $1.1M | $114.0K | ||||||||||||
| Increase Decrease In Accounts Payable | $1.6M | -$5.9M | -$6.7M | $5.9M | -$198.0K | $3.0K | ||||||||||||
| Net Cash Provided By Used In Investing Activities | $15.3M | -$219.3M | $12.2M | -$39.5M | $0.00 | -$52.0K | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $187.0K | $0.00 | $0.00 | $18.0K | $0.00 | $52.0K | ||||||||||||
| Increase Decrease In Other Current Assets | -$17.0K | -$9.0K | $4.0K | -$271.0K | $0.00 | |||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 1.5M | 6.9M | 240.0K | 234.0K | 342.0K | |||||||||||||
| Payments To Acquire Marketable Securities | $90.0M | $255.0M | $34.2M | $39.4M | $0.00 | |||||||||||||
| Depreciation Amortization And Accretion Net | -$1.5M | -$506.0K | $9.0K | $35.0K | $108.0K | |||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $106.2M | $31.7M | $36.9M | $0.00 | ||||||||||||||
| Proceeds From Issuance Of Common Stock Follow On Offering | $0.00 | $287.5M | $115.0M | $86.1M | ||||||||||||||
| Payments Of Stock Issuance Costs On Follow On Offering | $0.00 | $17.9M | $7.3M | $6.1M | ||||||||||||||
| Increase Decrease In Operating Lease Liability | -$394.0K | -$637.0K | -$680.0K | -$626.0K | ||||||||||||||
| Proceeds From Sale Of Marketable Securities | $0.00 | $4.0M | $9.5M | $0.00 | ||||||||||||||
| Proceeds From Short Swing Settlement | $0.00 | $37.0K | $0.00 | |||||||||||||||
| Payments For Restructuring | $0.00 | $590.0K | $29.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$4.66 | -$2.75 | -$2.25 | -$3.35 | -$2.43 | -$166.93 |
| Weighted Average Number Of Shares Outstanding Basic | 64.2M | 55.3M | 42.7M | 26.6M | 13.4M | |
| Weighted Average Number Of Diluted Shares Outstanding | 64.2M | 55.3M | 42.7M | 26.6M | 13.4M | |
| Earnings Per Share Basic | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 13.4M | 320.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.26 | -$1.20 | -$0.81 | -$0.85 | -$0.62 | -$0.56 | -$0.45 | -$0.46 | -$0.80 | -$0.91 | -$0.55 | -$0.71 | -$0.36 | -$0.33 | -$12.23 | -$13.68 | -$11.10 | -$7.79 | |
| Weighted Average Number Of Shares Outstanding Basic | 63.8M | 63.8M | 63.7M | 54.9M | 54.7M | 51.0M | 44.4M | 44.3M | 37.7M | 27.2M | 27.1M | 24.2M | 21.3M | 10.5M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 63.8M | 63.8M | 63.7M | 54.9M | 54.7M | 51.0M | 44.4M | 44.3M | 37.7M | 27.2M | 27.1M | 24.2M | 21.3M | 10.5M | |||||
| Earnings Per Share Basic | $-1.26 | $-1.20 | $-0.81 | $-0.85 | $-0.62 | $-0.56 | $-0.45 | $-0.46 | $-0.80 | $-0.91 | $-0.55 | $-0.71 | $-0.36 | $-0.33 | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 24.2M | 21.3M | 10.5M | 385.4K | 326.0K | 324.7K | 317.7K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $5.7M | $12.9M | $781.0K | $1.8M | $550.0K | $282.0K |
| Investment Income Interest | $24.5M | $20.7M | $8.0M | $1.8M | $15.0K | $8.0K |
| Other Income | -$1.1M | $1.9M | $1.8M | $1.9M | $0.00 | |
| Interest Paid Net | $6.7M | $6.7M | $3.4M | $895.0K | $17.0K | $32.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.3M | $545.0K | $275.0K | $291.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | $31.0K | $464.0K | $982.0K | $505.0K | $3.4M | $6.6M | $197.0K | $432.0K | $65.0K | $853.0K | $47.0K | $65.0K | $208.0K | $342.0K | $1.0K | $15.0K | ||
| Investment Income Interest | $5.7M | $6.3M | $6.9M | $4.8M | $5.1M | $4.2M | $2.2M | $2.2M | $1.6M | $567.0K | $263.0K | $26.0K | $5.0K | $2.0K | $2.0K | $0.00 | $6.0K | |
| Other Income | -$137.0K | -$836.0K | $386.0K | $344.0K | $443.0K | $449.0K | $437.0K | $511.0K | $441.0K | $347.0K | $325.0K | $315.0K | $0.00 | $0.00 | $0.00 | |||
| Interest Paid Net | $1.6M | $1.5M | $3.3M | $104.0K | $0.00 | |||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $766.0K | $551.0K | $247.0K | $298.0K | $101.0K | $175.0K | $122.0K | $169.0K |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.